Abstract
Medication nonadherence is a pervasive medical problem that is common among patients with chronic disease generally and type 2 diabetes in particular. There are two types of nonadherence (i) unintentional nonadherence and (ii) intentional nonadherence. To evaluate medication adherence in type 2 diabetes patients, determine the outcome of the therapeutic management in the level of blood glucose. The present study is a prospective cross sectional pilot study, it was conducted for 12 weeks, between January and March 2012, by using research questionnaire, Morisky 8-Item Self-Report. 103 patients are selected randomly and interviewed. Of the selected patients, 20.39% patients were completely lost the follow-up, 5.82% patients were not regularly visiting and 3.88% was declined to give consent. Rest of the 72 patients are the subjected for the further studies. 72 subjects, 62.5% were male and 37.5% were female. 94.44% were married and 75% of the subject was completed their graduation while 15.28% was completed secondary school whereas 9.72% do not have any formal education. The occupation of the subjects represented that 47.22% were employed, 40.28% were self-employed and 12.5% were unemployed. 91.67% of subjects HBA1C level was in abnormal category. The total cholesterol level was also measured, 58.33% subjects were having abnormal level (< 200mg/dl). Medication nonadherence of ambulatory type 2 diabetes patients is seen significant. Missing of dose, forgetfulness and expenditure on medicines were the highly observed factor for the medication compliance. Nevertheless, low level of adherence shown to have considerably affected on patients’ blood glucose level since large number subjects had blood glucose level was in abnormal level. Pharmacists can help to upsurge the medication adherence and self-management practices of these subjects in the study site to achieve maximum benefits of prescribed treatment regimen.
References
International Diabetes Federation. Diabetes Prevalence, 2005. http://www.idf. org/home/index.cfm? – Accessed on 01/07/2012.
King H and Rewers M. Global estimates for the prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Reporting Group. Diabetes Care. 1993; 16: 157 – 177.
Priya Shetty. Public health: India's diabetes time bomb. Nature, 2012; 485: S14–S16. Available from – http://www.nature.com/nature/journal/v485/n7398_supp/full/485S14a.html - Accessed on 01/07/2012.
Helmrich SP, Rayland RW, Leung RS and Paffen- berger. Physical activity and reduced occurrence of NIDDM. N Engl J Med., 1991; 325(4): 147 – 151.
Mark AM, Benjamen W and Van Tassell JL. Medication nonadherence: An unrecognized cardiovascular risk factor. Mediscape General Medicine, 2007; 9(3): 58.
Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004; 27: 1218 – 1224.
Robert Horne. In: Kevin Taylor and Geoffery Harding, editors. Pharmacy Practice. 1st Ed. New York. Taylor & Francis Publishing; 2005.
WHO. Noncomunicable diseases and mental health: Adherence to long-term therapies project, 2003.
Adisa R, Fakeye TO, Fasanmade A. Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in southwestern Nigeria. Pharmacy Practice (Internet), 2011; 9(2): 72 – 81.
Anderson DKG and Svardsudd K: Long term glycemic control relates to mortality in type 2 diabetes. Diabetes Care. 1995; 18: 1534 – 1543.
Ohkubo Y, Kishikawa H, Araki E, Isamis S, Motoyoshi, Kojima Y, Furuyoshi N and Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract., 1995; 28: 103 – 117.
Jacques CHM and Jones RL: Problems encountered by primary care physicians in the care of patients with diabetes. Arch Fam Med., 1993; 2: 739 – 741.
Lutfey KE and Wishner WJ. Beyond “Compliance’’ is “adherence’’. Improving the prospect of diabetes care. Diabetes Care. 1999; 22: 635 – 639.
Hinchageri S. S, Neelkanthreddy Patil, Khavane Karan, Bhanda Shalini and Swarnakamala K. Assessment of medication adherence and factors affecting to medication adherence in asthma patients by clinical pharmacist. IRJP, 2012; 3(3): 211 – 215.
Rubin RR and Peyrot M. Men and Diabetes: Psychosocial and Behavioural issues. Diabetes Spectrum. 1998; 11: 81 – 87.
Mckay HG, Boles SM and Glasgow RE. Personality (Conscientiousness) and environmental (barriers) factors related to diabetes self management and quality of life. Diabetes Care. 1998; 44: 170 – 173.
Morisky DE, Green LW and Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 1986; 24: 67 – 74.
ICMR, Guidelines for the Management of Type 2 Diabetes, 2005.
Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive Validity of a Medication Adherence Measure for Hypertension Control. J Clin Hyperten., 2008; 10(5): 348 – 354.
Mehuys E, Bortel LV, Bolle LD, Tongelen IV, Annemans L, Remon JP et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J., 2008; 31: 790 – 799.
Botelho R and Dudrak R. Home Assessment of adherence to long –term medication in the elderly. J Family Pract., 1992; 35: 61 – 64.
Anderson R and Kirk L. Methods of improving patient compliance in chronic disease state. Arch Intern Med., 1982; 142: 1673 – 1675.
http://www.healthizen.com/health-special/world-obesity-day/bmi-in-indians.aspx – accessed on December 2011.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array